| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/19/2013 | US20130245063 Compounds that modulate intracellular calcium |
| 09/19/2013 | US20130245040 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
| 09/19/2013 | US20130245011 Modulators of ATP-Binding Cassette Transporters |
| 09/19/2013 | US20130245010 Modulators of atp-binding cassette transporters |
| 09/19/2013 | US20130245005 Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases |
| 09/19/2013 | US20130244996 Benzodioxane inhibitors of leukotriene production |
| 09/19/2013 | US20130244966 Fatty acid antiviral conjugates and their uses |
| 09/19/2013 | DE102013003605A1 Sekundäre Lochtransportschicht mit Tricarbazolverbindungen Secondary hole transport layer with Tricarbazolverbindungen |
| 09/18/2013 | EP2639226A1 Anti-infective pyrimidines and uses thereof |
| 09/18/2013 | EP2639224A1 Process for producing cycloalkylcarboxiamido-pyridine benzoic acids |
| 09/18/2013 | EP2639223A1 Process for producing cycloalkylcarboxiamido-pyridine benzoic acids |
| 09/18/2013 | EP2639222A1 Process for producing cycloalkylcarboxiamido-pyridine benzoic acids |
| 09/18/2013 | EP2638036A1 Compound for increasing kinase active and application thereof |
| 09/18/2013 | EP2638035A1 Triazole derivatives as ligands for gaba receptors |
| 09/18/2013 | EP2638034A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| 09/18/2013 | EP2638031A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators |
| 09/18/2013 | EP2638029A1 Triazole derivatives and their use for neurological disorders |
| 09/18/2013 | EP2638018A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors |
| 09/18/2013 | CN103313980A Biscarbazole derivative and organic electroluminescent element using same |
| 09/18/2013 | CN103313978A Pyrazole aminopyrimidine derivatives as LRRK2 modulators |
| 09/18/2013 | CN103313977A 1-(heterocyclic carbonyl) piperidines |
| 09/18/2013 | CN103313976A SGC stimulators |
| 09/18/2013 | CN103313972A Pyrazol-4-yl carboxamide derivatives as microbiocides |
| 09/18/2013 | CN103313970A Novel bicyclic compound or salt thereof |
| 09/18/2013 | CN103304571A Spiro compound as well as preparation method, intermediate, pharmaceutical composition and application thereof |
| 09/18/2013 | CN103304552A Substituted pyridine compound as well as application method and usage thereof |
| 09/18/2013 | CN103304551A Hepatitis C polymerase inhibitor |
| 09/18/2013 | CN103304550A Preparation method of Olmesartan Medoxomil |
| 09/18/2013 | CN103304549A Jaspine B, 3-epi Jaspine B triazole derivative as well as preparation method and application thereof |
| 09/18/2013 | CN103304548A N'-(2-aminopyridine)-7-lignocaine-3-formamide-coumarin as well as preparation method and application thereof |
| 09/18/2013 | CN103304547A Preparation method of antidepressant drug-vilazodone |
| 09/18/2013 | CN103304546A Pyrazoline derivatives comprising 1,4-benzodioxan structure, and preparation method and application thereof |
| 09/18/2013 | CN103304545A 5-amino-1,4-disubstituent-1,2,3-triazole and preparation method thereof |
| 09/18/2013 | CN103304544A Polymorphic substances of 4-(substituted anilino)quinazoline derivative xylene sulfonate, and preparation method and application thereof |
| 09/18/2013 | CN103304541A Viral polymerase inhibitors |
| 09/18/2013 | CN103304483A N-3-arylamine-5-cyclopropane spirohydantoin and preparation method and application thereof |
| 09/18/2013 | CN103301868A Core-shell structural nano catalyst as well as preparation method and application thereof |
| 09/18/2013 | CN102532016B 5-aminoquinoline-2(1H) ketone compound and synthetic method and application thereof |
| 09/18/2013 | CN102304112B Vesicle with two-photon excitation controlled-release function, and preparation method and application thereof |
| 09/18/2013 | CN102006873B Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/18/2013 | CN101878199B 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 09/17/2013 | US8536340 Cross-linked cyclic amine compounds and agents for pest control |
| 09/17/2013 | US8536229 Acetylene derivatives having MGluR 5 antagonistic activity |
| 09/17/2013 | US8536198 Piperidine derivatives as modulators of chemokine receptor activity |
| 09/17/2013 | US8536182 Benzylpiperazine derivatives and their medical use |
| 09/17/2013 | US8536092 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents |
| 09/17/2013 | US8535885 Detection of disease related genes |
| 09/17/2013 | CA2607280C Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| 09/17/2013 | CA2541059C Fluorescent probes for use in protein kinase inhibitor binding assay |
| 09/17/2013 | CA2498644C Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
| 09/12/2013 | WO2013134415A1 Mannose derivatives for treating bacterial infections |
| 09/12/2013 | WO2013134226A1 Benzodioxanes for inhibiting leukotriene production |
| 09/12/2013 | WO2013133218A1 Photoelectric conversion element, method for using same, imaging element, optical sensor, and chemical |
| 09/12/2013 | WO2013132509A1 Novel compounds for the treatment of dyslipidemia and related diseases |
| 09/12/2013 | WO2013132253A1 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| 09/12/2013 | WO2013131901A1 Benzodioxanes in combination with other actives for inhibiting leukotriene production |
| 09/12/2013 | WO2013131465A1 Polymorphs of n-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfinyl)ethylamino)methyl)-2-furanyl)-quinazoline-4-aminexylene sulfonate and preparation method and uses thereof |
| 09/12/2013 | WO2013109972A3 Therapeutic compounds |
| 09/12/2013 | US20130237705 Method for manufacture of 2-oxoimidazolidines |
| 09/12/2013 | US20130237568 Modulators of atp-binding cassette transporters |
| 09/12/2013 | US20130237552 Sulfur derivatives as chemokine receptor modulators |
| 09/12/2013 | US20130237541 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| 09/12/2013 | US20130237536 Heterocyclic modulators of cannabinoid receptors |
| 09/12/2013 | US20130237528 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 09/12/2013 | US20130237518 Novel compounds that are erk inhibitors |
| 09/12/2013 | US20130237514 Pyrrolidinone carboxamide derivatives |
| 09/12/2013 | US20130237500 N-aryl pyrazole(thio)carboxamides |
| 09/11/2013 | EP2636414A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase |
| 09/11/2013 | EP2635564A1 N-hetarylmethyl pyrazolylcarboxamides |
| 09/11/2013 | EP2635557A2 Nicotinamides as jak kinase modulators |
| 09/11/2013 | EP2635280A2 Cytosine deaminase modulators for enhancement of dna transfection |
| 09/11/2013 | EP2635274A1 Anti-staphylococcal celecoxib derivatives |
| 09/11/2013 | CN1665807B Novel physiolgically active substances |
| 09/11/2013 | CN103298805A Quinazoline compounds and methods of use thereof |
| 09/11/2013 | CN103298802A N-hetarylmethyl pyrazolylcarboxamides |
| 09/11/2013 | CN103298797A Method of preparation of metaxalone |
| 09/11/2013 | CN103298794A Pyridine compounds and aza analogues thereof as TYK2 inhibitors |
| 09/11/2013 | CN103288871A Intermediate for preparing dihydroxy acid HMG-CoA reductase inhibitor, and preparation method and applications thereof |
| 09/11/2013 | CN103288808A Preparation method of afatinib (I) |
| 09/11/2013 | CN103288807A Alkaloid separated from Tripterygium wilfordii endophytic fungus metabolite and application thereof |
| 09/11/2013 | CN103288806A Synthesis method of troxacitabine |
| 09/11/2013 | CN103288805A Benzofuran-containing pyrimidine compound, its preparation method and use |
| 09/11/2013 | CN103288793A Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/11/2013 | CN103288754A Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same |
| 09/11/2013 | CN103288753A Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors |
| 09/11/2013 | CN103288747A 6-Cyclohexylmethyl-2-aromatic ring carbonyl substituted N-DABO compounds, and synthetic method and use thereof |
| 09/11/2013 | CN103288738A Nitrogen-containing heterocyclic derivative having 11 beta-hydroxysteroid dehydrogenase type I inhibitory activity |
| 09/11/2013 | CN103288721A (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-n-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof |
| 09/11/2013 | CN102225936B Processes for producing compound |
| 09/11/2013 | CN102086211B Aromatic heterocyclic compounds serving as protein kinase inhibitor |
| 09/11/2013 | CN101993416B Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound |
| 09/11/2013 | CN101657441B Pyrazolone derivatives as PDE4 inhibitors |
| 09/11/2013 | CN101365676B Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 09/10/2013 | US8530667 Herbicides |
| 09/10/2013 | US8530499 Glucokinase activators |
| 09/10/2013 | US8530476 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 09/10/2013 | US8530462 Indole modulators of S1P receptors |
| 09/10/2013 | CA2758894C Novel thyroid hormone .beta. receptor agonist |
| 09/10/2013 | CA2669687C Phthalazine derivatives |